Publications:275
- Home
- Profiles
Mount Sinai DoctorsMaria I Fiel, MD
No Patient Experience Ratings
- About Me
- Clinical Focus
- Education & Certifications
- Research
- Insurance
- Publications
- Industry Relationships
About Me
Clinical Interests
Liver Pathology, Gastrointestinal Pathology, and Cytopathology.
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
About Me
Clinical Interests
Liver Pathology, Gastrointestinal Pathology, and Cytopathology.
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
Clinical Focus
- Adenomas
- Amyloidosis
- Autoimmune Hepatitis
- Bile Duct Diseases
- Biopsy
- Cholangiocarcinoma
- Cirrhosis
- Colon Polyps
- Colorectal Cancer
Show More
- Adenomas
- Amyloidosis
- Autoimmune Hepatitis
- Bile Duct Diseases
- Biopsy
- Cholangiocarcinoma
- Cirrhosis
- Colon Polyps
- Colorectal Cancer
- Esophageal Cancer
- Fatty Liver Disease
- Hemangioma
- Hepatitis B
- Hepatitis C
- Hepatocellular Carcinoma
- IBD
- Liver Cancer
- Liver Transplant
- Peptic Ulcer
- Small Bowel Resection
- Ulcerative Colitis
Education
MD, University Of The East Ramon Magsaysay Memorial Medical College Of Medicine
Residency, Internal Medicine
Ormoc District Hospital
Residency, Internal Medicine
OSPA-Farmers' Medical Center
Residency, Pathology
Mount Sinai Hospital
Fellowship, Cytopathology
Mount Sinai Hospital
Fellowship, Pathology
Mount Sinai Hospital
Certifications
American Board of Pathology
Research
Dr. Fiel is the Core Director of the Mount Sinai Alcoholic Liver Disease Research Center.
Insurance Information
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: a cross-trial, patient-level analysis. Antonio D'Alessio, Bernardo Stefanini, Julia Blanter, Benjamin Adegbite, Fionnuala Crowley, Vincent Yip, Sarah Slater, Claudia Angela Maria Fulgenzi, Ciro Celsa, Giulia Francesca Manfredi, Madhava Pai, Robert D. Goldin, Stephen C. Ward, Maria Isabel Fiel, Daniel H. Shu, Yung Yeh Su, Alessio Cortellini, Marina Baretti, Robert Anders, Mark Yarchoan, Chiun Hsu, Thomas U. Marron, David J. Pinato. The Lancet Oncology
- The Spatial Extracellular Proteomic Tumor Microenvironment Distinguishes Molecular Subtypes of Hepatocellular Carcinoma. Jade K. Macdonald, Harrison B. Taylor, Mengjun Wang, Andrew Delacourt, Christin Edge, David N. Lewin, Naoto Kubota, Naoto Fujiwara, Fahmida Rasha, Cesia A. Marquez, Atsushi Ono, Shiro Oka, Kazuaki Chayama, Sara Lewis, Bachir Taouli, Myron Schwartz, M. Isabel Fiel, Richard R. Drake, Yujin Hoshida, Anand S. Mehta, Peggi M. Angel. Journal of Proteome Research
- Obliterative Portal Venopathy during Estrogen Therapy in a Transgender Woman: A Case Report. Nathaniel S. Ash, Thomas D. Schiano, Joshua D. Safer, Maria I. Fiel, Aren H. Skolnick, Nancy Bach. Livers
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Fiel during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Bristol-Myers Squibb
- Merck Sharp & Dohme Corp
- Regeneron Pharmaceuticals, Inc.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Fiel during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Bristol-Myers Squibb
- Merck Sharp & Dohme Corp
- Regeneron Pharmaceuticals, Inc.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.